CETIRIZINE HYDROCHLORIDE
Details
- Status
- Prescription
- First Approved
- 2008-05-27
- Routes
- ORAL
- Dosage Forms
- SOLUTION, TABLET, ORALLY DISINTEGRATING, TABLET
Companies
CETIRIZINE HYDROCHLORIDE Approval History
What CETIRIZINE HYDROCHLORIDE Treats
15 FDA approvalsOriginally approved for its first indication in 2008 . Covers 15 distinct patient populations.
- Other (15)
Other
(15 approvals)- • Approved indication (May 2008)
- • Approved indication (Jun 2008)
- • Approved indication (Jun 2008)
- • Approved indication (Jun 2008)
- • Approved indication (Oct 2008)
- • Approved indication (Apr 2009)
- • Approved indication (Aug 2009)
- • Approved indication (Sep 2009)
- • Approved indication (Oct 2009)
- • Approved indication (Nov 2009)
- • Approved indication (Dec 2009)
- • Approved indication (Feb 2010)
- • Approved indication (May 2012)
- • Approved indication (Sep 2020)
- • Approved indication (Oct 2024)
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CETIRIZINE HYDROCHLORIDE FDA Label Details
ProIndications & Usage
Perennial Allergic Rhinitis Cetirizine hydrochloride oral solution, USP is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing. Chronic Urticaria Cetirizine hydrochloride oral solution, USP is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age. It significantly...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.